Founded by UC Berkeley scientists, GenEdit is a genome editing company that is developing delivery technologies for CRISPR/Cas9 based therapeutics.
At GenEdit, we’re focused on developing CRISPR based therapeutics that will change our world.
Professor George Church, Harvard
Scientific advisory board
Mattew Rabinowitz, CEO of Natera
Stephanie Marrus, Director of UCSF Entrepreneurship center